FAS REPRESENTATIVES ANSWERED QUESTIONS FROM STATE PHARMACIES DURING ROUND TABLE AT STATE DUMA

02-07-2019 | 17:05

They focused on wholesale ex-works pricing for narcotic and psychotropic agents

 

Nadezhda Sharavskaya, Deputy Head of FAS Department for Control over Social Sphere and Trade took part in the Round Table “Operations of Pharmaceutical Companies with State Participation in Socially-Important Measures: Problems of Legislative Regulation” at the State Duma. The event was attended by Heads and representatives of state pharmacies, Healthcare Ministries of regions of Russia, the Ministry of Healthcare of the Russian Federation and Roszdravnadzor [the Federal Service for Surveillance in Healthcare].

 

Answering the question on ex-works pricing for narcotic and psychotropic agents included in the list of vital and essential drugs by wholesalers that have retail units, Nadezhda Sharavskaya explained that the current law does not include retail mark-ups in the prices for narcotic and psychotropic agents supplied to medical facilities. At the same time, wholesale mark-ups for sale of such drugs are set only in 59 regions of Russia, retail - in 62. In other regions, averaged mark-ups are set that do not allow wholesale pharmaceutical companies to compensate higher costs for sale of narcotic and psychotropic agents. The speaker informed that in this context FAS had issued explanations that mention possible adjustment of the ceiling wholesale mark-ups.

 

Deputy Head of FAS Department for Control over Social Sphere and Trade outlined the FAS position: “Regions analyze and review ceiling wholesale mark-ups annual on the basis of estimates submitted by wholesalers and retailers to local executive bodies. In view of the specifics of sale of narcotic and psychotropic agents, wholesalers can include in such analysis their costs related to sale of such medicines to medical establishments that do not have pharmacies in their structure”. 

 



Site Map

News & Events Press Releases Image Library About FAS Russia What We Do Institutional Memory Mission, Goals, Values Priority Setting Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings Using our website International Cooperation Treaties & Agreements OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 OECD meetings 2019 OECD meetings 2020 OECD meetings 2021 FAS Annual Reports OECD-GVH RCC RCC Newsletter Projects ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD 18th session IGE UNCTAD 8th UN Conference on Competition 19th session IGE UNCTAD 20th session IGE UNCTAD 21th session IGE UNCTAD EEU Model Law on Competition ICN BRICS BRICS Conferences Documents BRICS Competition Law and Policy Centre BRICS Working Groups for the Research of Competition Issues in Socially Important markets Working Group for the Research of Competition Issues in the Pharmaceutical Markets Working Group for the Research of Competition Issues in the Food Value Chains Working Group for the Research of Competition Issues in the Automobile Markets Working Group for the Research of Competition Issues in the Digital Markets BRICS Coordination Committee on antimonopoly policy EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Document Library Legislation Reports & Analytics Cases & decisions COVID-19 Contacts Give feedback Contact us Links Authorities Worldwide